Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corneel Coens

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Progression-free survival as a potential surrogate end point for overall survival in advanced cervical carcinomaRamon Yarza, Melpomeni Kountouri, Helena Guedes, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2008
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancerAndrew Bottomley, Channa Debruyne, Enriqueta Felip, et al.
The Lancet. Oncology|August 22, 2009
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trialsChantal Quinten, Corneel Coens, Murielle Mauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trialsLily Claassens, Jan van Meerbeeck, Corneel Coens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyAndrew Bottomley, Rabab Gaafar, Rabab Gaafa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2005
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?Fabio Efficace, Andrew Bottomley, Corneel Coens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 12, 2018
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant ChemotherapyParvin Tajik, Roelien van de Vrie, Mohammad H Zafarmand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group StudyAndrew Bottomley, Laura Biganzoli, Tanja Cufer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 9, 2025
Progression-free survival as a surrogate of overall survival in metastatic or recurrent endometrial cancer: an EORTC gynecologic cancer group studyRamon Yarza, Aranzazu Barquin, Giuseppe Caruso, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
Progression-free survival as a potential surrogate end point for overall survival in advanced cervical carcinomaRamon Yarza, Melpomeni Kountouri, Helena Guedes, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2008
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancerAndrew Bottomley, Channa Debruyne, Enriqueta Felip, et al.
The Lancet. Oncology|August 22, 2009
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trialsChantal Quinten, Corneel Coens, Murielle Mauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trialsLily Claassens, Jan van Meerbeeck, Corneel Coens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyAndrew Bottomley, Rabab Gaafar, Rabab Gaafa, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2005
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?Fabio Efficace, Andrew Bottomley, Corneel Coens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 12, 2018
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant ChemotherapyParvin Tajik, Roelien van de Vrie, Mohammad H Zafarmand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group StudyAndrew Bottomley, Laura Biganzoli, Tanja Cufer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 9, 2025
Progression-free survival as a surrogate of overall survival in metastatic or recurrent endometrial cancer: an EORTC gynecologic cancer group studyRamon Yarza, Aranzazu Barquin, Giuseppe Caruso, et al.
Pageof 13